Le Lézard
Classified in: Health, Science and technology
Subjects: Conference, Trade Show

BIO International Convention Begins Day Three with Jamie Dimon Keynote Address

The 2019 BIO International Convention, the premier life sciences event running through June 6 at the Philadelphia Convention Center, will open its third day of programming with a keynote from Jamie Dimon, Chairman and CEO of JPMorgan Chase. Dimon will be interviewed by BIO President and CEO Jim Greenwood on how emerging biotech companies can best position themselves in the global economy. Dimon will also share insight on how the industry can improve employee satisfaction and cultivate a diverse and inclusive biotech community.

The day's programming will also include compelling sessions with industry thought leaders, rising start-up companies as well as a fireside chat with Merck Chairman and CEO Ken Frazier. During his fireside chat, Frazier will discuss how Merck approaches investment in research and how that translates to delivering innovative, lifesaving medicines and vaccines and sustainable value for its stakeholders.

Wednesday, June 5, Highlights Include:

Follow the 2019 Convention @BIOConvention and join the conversation @IAmBIOtech.

About BIO

BIO is the world's largest trade association representing biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products. BIO also produces the BIO International Convention, the world's largest gathering of the biotechnology industry, along with industry-leading investor and partnering meetings held around the world. BIOtechNOW is BIO's blog chronicling "innovations transforming our world" and the BIO Newsletter is the organization's bi-weekly email newsletter. Subscribe to the BIO Newsletter.

These press releases may also interest you

at 08:35
BlackThorn Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on developing targeted medicines to treat central nervous system (CNS) disorders, today announced data supporting Phase 2 development of its lead drug candidate,...

at 08:35
NeoImmuneTech, Inc., a clinical-stage T cell-focused biopharmaceutical company, announced today it has entered into a clinical collaboration agreement with Merck, known as MSD outside of the United States and Canada, through a subsidiary, to evaluate...

at 08:35
Kite, a Gilead Company , and Kiniksa Pharmaceuticals, Ltd. ("Kiniksa") announced today that the companies have entered into a clinical collaboration to conduct a Phase 2, multicenter study of mavrilimumab, an investigational fully human monoclonal...

at 08:35
Resverlogix Corp. ("Resverlogix" or the "Company") today announced that Dr. Eldon Smith has stepped down from the Board of Directors, effective today. "We would like to thank Eldon for his many years of service and wish him all the best," said...

at 08:33
Nambe Drugs, a family-owned pharmacy located in Los Alamos and Santa Fe, is now carrying AllerPops, a natural allergy remedy that works by correcting the underlying cause of allergies instead of masking the symptoms. "I think it's going to be a...

at 08:32
Debbie's Dream Foundation: Curing Stomach Cancer (DDF) will host the 11th Annual Night of Laughter on Sunday, January 26, 2020, at the Palm Beach Improv Comedy Club. Doors will open at 4:00 p.m., and the show begins promptly at 5:00 p.m. The night...

News published on 5 june 2019 at 07:05 and distributed by: